AR023726A1 - Terapia con gch para el tratamiento del cancer de mama - Google Patents

Terapia con gch para el tratamiento del cancer de mama

Info

Publication number
AR023726A1
AR023726A1 ARP990106407A ARP990106407A AR023726A1 AR 023726 A1 AR023726 A1 AR 023726A1 AR P990106407 A ARP990106407 A AR P990106407A AR P990106407 A ARP990106407 A AR P990106407A AR 023726 A1 AR023726 A1 AR 023726A1
Authority
AR
Argentina
Prior art keywords
gch
treatment
cancer
therapy
mama
Prior art date
Application number
ARP990106407A
Other languages
English (en)
Original Assignee
Fox Chase Ct
Applied Research Systems
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fox Chase Ct, Applied Research Systems filed Critical Fox Chase Ct
Publication of AR023726A1 publication Critical patent/AR023726A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Endocrinology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La invencion se refiere al campo de la terapia contra el cáncer. Más particularmente, la invencion se refiere al tratamiento de tumores mamarios, lostumores mamarios clínicamente manifiestos (cáncer de mama), y los tumores de mama metastásicos mediante la administracion de Gonadotropina corionica humana(GCh). El tratamiento preferentemente consiste en la administracion de GCh junto con un antiestrogeno y/o Interferon Tipo I.
ARP990106407A 1998-12-15 1999-12-15 Terapia con gch para el tratamiento del cancer de mama AR023726A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP98123817A EP1013281A1 (en) 1998-12-15 1998-12-15 hCG therapy for the treatment of breast cancer

Publications (1)

Publication Number Publication Date
AR023726A1 true AR023726A1 (es) 2002-09-04

Family

ID=8233138

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP990106407A AR023726A1 (es) 1998-12-15 1999-12-15 Terapia con gch para el tratamiento del cancer de mama

Country Status (16)

Country Link
US (1) US7183251B1 (es)
EP (2) EP1013281A1 (es)
JP (1) JP2003523311A (es)
AR (1) AR023726A1 (es)
AT (1) ATE353664T1 (es)
AU (1) AU781495B2 (es)
BR (1) BR9916221A (es)
CA (1) CA2351726A1 (es)
CY (1) CY1106525T1 (es)
DE (1) DE69935156T2 (es)
DK (1) DK1140147T3 (es)
ES (1) ES2277461T3 (es)
IL (2) IL143671A0 (es)
PT (1) PT1140147E (es)
SI (1) SI1140147T1 (es)
WO (1) WO2000035469A2 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2582567A1 (en) * 2004-10-07 2006-04-13 Stem Cell Therapeutics Corp. Stimulation of proliferation of pluripotential stem cells through administration of pregnancy associated compounds
US9186128B2 (en) 2008-10-01 2015-11-17 Covidien Lp Needle biopsy device
US11298113B2 (en) 2008-10-01 2022-04-12 Covidien Lp Device for needle biopsy with integrated needle protection
US9782565B2 (en) 2008-10-01 2017-10-10 Covidien Lp Endoscopic ultrasound-guided biliary access system
US8968210B2 (en) * 2008-10-01 2015-03-03 Covidien LLP Device for needle biopsy with integrated needle protection
US9332973B2 (en) 2008-10-01 2016-05-10 Covidien Lp Needle biopsy device with exchangeable needle and integrated needle protection

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0578328B1 (en) 1983-11-02 1999-12-29 Applied Research Systems ARS Holding N.V. Material and methods for the production of a heterodimeric human LH with a Met42 Val55 alpha subunit
US5677275A (en) 1994-08-05 1997-10-14 The United States Of America As Represented By The Department Of Health And Human Services Treatment of cancer with human chorionic gonadotropin
US5700781A (en) 1994-10-04 1997-12-23 Harris; Pamela Jo Method for treating Kaposi's sarcoma and HIV infections
US5997871A (en) * 1996-06-24 1999-12-07 University Of Maryland Biotechnology Insitute Treatment and prevention of cancer by administration of derivatives of human chorionic gonadotropin

Also Published As

Publication number Publication date
ES2277461T3 (es) 2007-07-01
AU2363100A (en) 2000-07-03
US7183251B1 (en) 2007-02-27
WO2000035469A3 (en) 2000-09-14
IL143671A (en) 2009-08-03
BR9916221A (pt) 2001-09-11
PT1140147E (pt) 2007-03-30
DK1140147T3 (da) 2007-03-26
CY1106525T1 (el) 2012-01-25
SI1140147T1 (sl) 2007-06-30
IL143671A0 (en) 2002-04-21
WO2000035469A2 (en) 2000-06-22
EP1140147B1 (en) 2007-02-14
DE69935156T2 (de) 2007-11-22
EP1013281A1 (en) 2000-06-28
ATE353664T1 (de) 2007-03-15
DE69935156D1 (de) 2007-03-29
EP1140147A2 (en) 2001-10-10
AU781495B2 (en) 2005-05-26
JP2003523311A (ja) 2003-08-05
WO2000035469A9 (en) 2001-03-22
CA2351726A1 (en) 2000-06-22

Similar Documents

Publication Publication Date Title
EA200800268A1 (ru) КОМБИНИРОВАННАЯ ТЕРАПИЯ АНТИТЕЛОМ ПРОТИВ CTLA-4 И СОДЕРЖАЩИМ CpG-МОТИВ СИНТЕТИЧЕСКИМ ОЛИГОДЕЗОКСИНУКЛЕОТИДОМ ДЛЯ ЛЕЧЕНИЯ ЗЛОКАЧЕСТВЕННОЙ ОПУХОЛИ
TR200003879T2 (tr) İn vivo ışın tedavisine duyarlılaştırıcı özelliklere sahip farnesil protein transferaz inhibitörleri@
DK1556058T3 (da) Farmaceutiske præparater omfattende östetrolderivater til anvendelse i cancerterapi
WO2002080754A3 (en) Methods for using annexin for detecting cell death in vivo and treating associated conditions
BRPI0207961A8 (pt) Uso de análogos de epotilona e capecitabina para fabricar medicamento para tratar tumores cancerosos sólidos e kit compreendendo os referidos compostos.
DK1228208T3 (da) 36P6D5: udskilt tumorantigen
UY28081A1 (es) Administracinn combinada de una indolinona con un agente quimioterapcutico para trastornos de proliferacinn celular
BG101290A (en) New promedicaments for the therapy of tumours and inflammatory diseases
PT1242060E (pt) Tratamento da doenca metastatica
HK1175846A1 (en) Cytotoxicity mediation of cells evidencing surface expression of cd44 cd44
CY1107815T1 (el) 1,3 - διϋποκατεστημεναι και 1,3,3 -τριϋποκατεστημεναι πυρρολιδιναι ως συνδεσμικα μεσα υποδοχεως ισταμινης -3, και θεραπευτικαι εφαρμογαι των
IL146125A0 (en) Novel quinones as disease therapies
BR9808509A (pt) Composições e métodos para o tratamento e diagnóstico do câncer de mama
DE60228544D1 (de) Triptolid-prodrugs zur krebstherapie
WO2004096159A3 (en) Saposin c-dops: a novel anti-tumor agent
WO2005065361A3 (en) Compounds and compositions for treating dysproliferative diseases, and methods of use thereof
AR023726A1 (es) Terapia con gch para el tratamiento del cancer de mama
ES2191784T3 (es) Vacunas de tumores de citocinas paracrinas alogenicas.
ES2073277T3 (es) Sustancias de naturaleza polipeptida utiles en la terapia humana.
SV2002000179A (es) Proceso para la preparacion de un compuesto para reducir el riesgo del cancer ref.x-13527-el
BR0111024A (pt) Composições e métodos para a terapia e diagnóstico de câncer de mama
BR9808263A (pt) Processos para tratar câncer em um humano em necessidade de tratamento e para manufaturar um medicamento para inibir o crescimento em um humano de um tumor sólido, e, uso de um composto.
BR0008305A (pt) Utilização de uma proteìna ompa de enterobactéria, ou de um de seus fragmentos e composição farmacêutica
ATE306255T1 (de) 19-nor-vitamin d3 derivate mit calciumspiegel erhöhender wirkung
ATE306283T1 (de) Biotin-derivate und ihre konjugaten mit chelatierungsmitteln

Legal Events

Date Code Title Description
FB Suspension of granting procedure